节点文献

FDZJ公司的瑞特普酶(Reteplase)项目管理的实证研究

The Reteplase Project Management Research of FDZJ Stock Co.Ltd.

【作者】 杨帆

【导师】 徐玖平;

【作者基本信息】 四川大学 , 工商管理, 2003, 硕士

【摘要】 瑞特普酶项目属生物制药项目,本文对FDZJ公司瑞特普酶项目的管理现状进行了详细分析,具体有待改进地方有:市场份额估计过高,市场定位本位化,市场调查注重不足;项目融资仅采用自筹资金及科技成果转让的方式;项目组织结构为传统的直线制,不利于集思广义,人员配备重研发人才,轻管理人才,人才储备工作欠缺,人员激励策略与项目长远利益不衔接;成本管理欠缺,忽视进度管理等。 本文在深刻剖析上述问题的基础上,运用项目管理方面的理论知识,充分阐述问题的解决方案,给予了有效的对策。其中包括:项目行业与竞争力分析,运用SWOT分析法评估公司资源和竞争能力,通过书面调查、访谈及查阅国内外相关文献等方式收集市场信息,在此基础上,进行项目的市场需求量预测,价格预测。成立集研发、生产、销售、财务及公关人才于一身的项目团队管理项目,并采用强矩阵结构,集合直线制与职能制的优势,对全体员工实行股份期权激励,使员工利益与项目形成命运共同体。对项目所需投资额进行估算,尽量吸引风险投资资金,分散融资风险等。 本文在进度管理方面,创新型的提出了瑞特普酶项目进度计划甘特图,实现项目研发、生产、销售一体化管理,期望能够对以后生物制药项目的实际操作有一定的借鉴和帮助。

【Abstract】 In this article, we give an exhaustive analysis on the management status quo of the Retapase Project, a Biopharmaceutics Project of FDZJ Company, and point out various weaknesses in its management that need to be improved. The market occupation of Retapase Project has been over appraised and the market orientation is based on self-reference while less weight has been put on market survey; The project fund comes inadequately from self-raised resources or by transferring the techniques. In the organization framework of the project, the conventional linear system is adopted, which inhibit imbibing the wisdom of majority; On personnel management, the R&D professionals have been weighed much more against the management professionals and little effort has been put on building the professionals reservoir, while the personnel incentive tactics are not conducive to the long benefit of the project In addition, the cost management is maldeveloped and the project progress controlling has been neglected.Based on the above-mentioned analysis, we use the theoretical knowledge of project management to elaborate the various possibilities to resolve the problems, and then put forward effective countermeasures, which include analyzing the competition strength of Retapase in the biopharmaceutical industry; evaluating the resources of the FDZJ company and its competition strength by using the SWOT analysis method, collecting the market information by questionnaire survey,interview and document retrieval of domestic and internal literatures.After this, we predict the market requirement and the price of the Rctapasc and propose to set up a project management team which can control the R&D, production, sales, finance and affair communicating personnel systematically. We also suggest to take the incentive mechanism of stock and future privilege to bind the benefit of personnel and that of projects together by adopting the structure of strong matrix and assembling the superiority of the linear system and that of the functional system. Furthermore, we suggest that the investment amount needed by the project should be evaluated in advance and investment capitals on stake should be attracted as much as possible to attenuate the risk of financing.In this article, we newly put forward a Gante Map of Relapse Project progress plan and help to realize the uniform management of Project R&D, production andsales, which can be expected to provide assistance and reference to the practical performance of Biopharmaceutical Projects.

【关键词】 生物制药瑞特普酶项目管理
【Key words】 BiopharmaceuticsReteplaseProject Management
  • 【网络出版投稿人】 四川大学
  • 【网络出版年期】2004年 02期
  • 【分类号】F279.26
  • 【下载频次】136
节点文献中: 

本文链接的文献网络图示:

本文的引文网络